{"title":"Quantitative assessment of the central versus peripheral effect of intravenous clonidine using baroreflex equilibrium diagrams.","authors":"Toru Kawada, Takuya Nishikawa, Yohsuke Hayama, Meihua Li, Can Zheng, Kazunori Uemura, Keita Saku, Tadayoshi Miyamoto, Masaru Sugimachi","doi":"10.1186/s12576-021-00824-y","DOIUrl":null,"url":null,"abstract":"<p><p>Clonidine is a first-generation central antihypertensive that reduces sympathetic nerve activity (SNA). Although clonidine also exerts peripheral vasoconstriction, the extent to which this vasoconstriction offsets the centrally mediated arterial pressure (AP)-lowering effect remains unknown. In anesthetized rats (n = 8), we examined SNA and AP responses to stepwise changes in carotid sinus pressure under control conditions and after intravenous low-dose (2 μg/kg) and high-dose clonidine (5 μg/kg). In the baroreflex equilibrium diagram analysis, the operating-point AP under the control condition was 115.2 (108.5-127.7) mmHg [median (25th-75th percentile range)]. While the operating-point AP after low-dose clonidine was not significantly different with or without the peripheral effect, the operating-point AP after high-dose clonidine was higher with the peripheral effect than without [81.3 (76.2-98.2) mmHg vs. 70.7 (57.7-96.9), P < 0.05]. The vasoconstrictive effect of clonidine partly offset the centrally mediated AP-lowering effect after high-dose administration.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10717658/pdf/","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12576-021-00824-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 5
Abstract
Clonidine is a first-generation central antihypertensive that reduces sympathetic nerve activity (SNA). Although clonidine also exerts peripheral vasoconstriction, the extent to which this vasoconstriction offsets the centrally mediated arterial pressure (AP)-lowering effect remains unknown. In anesthetized rats (n = 8), we examined SNA and AP responses to stepwise changes in carotid sinus pressure under control conditions and after intravenous low-dose (2 μg/kg) and high-dose clonidine (5 μg/kg). In the baroreflex equilibrium diagram analysis, the operating-point AP under the control condition was 115.2 (108.5-127.7) mmHg [median (25th-75th percentile range)]. While the operating-point AP after low-dose clonidine was not significantly different with or without the peripheral effect, the operating-point AP after high-dose clonidine was higher with the peripheral effect than without [81.3 (76.2-98.2) mmHg vs. 70.7 (57.7-96.9), P < 0.05]. The vasoconstrictive effect of clonidine partly offset the centrally mediated AP-lowering effect after high-dose administration.
氯硝安定是第一代中枢降压药,可降低交感神经活性(SNA)。虽然氯尼地平也会产生外周血管收缩,但这种血管收缩在多大程度上抵消了中枢介导的动脉压(AP)降低效应仍是未知数。在麻醉大鼠(n = 8)中,我们检测了在控制条件下以及静脉注射低剂量(2 μg/kg)和高剂量(5 μg/kg)氯尼丁后,SNA 和 AP 对颈动脉窦压力阶跃变化的反应。在气压反射平衡图分析中,对照组条件下的工作点 AP 为 115.2 (108.5-127.7) mmHg [中位数(第 25-75 百分位数范围)]。虽然小剂量氯尼丁后的操作点 AP 在有无外周效应时没有显著差异,但大剂量氯尼丁后的操作点 AP 在有外周效应时高于无外周效应时 [81.3 (76.2-98.2) mmHg vs. 70.7 (57.7-96.9), P